Craft

Immuno-Biological Laboratories

Stock Price

¥520

2024-10-29

Market Capitalization

¥4.8 B

2024-10-29

Revenue

¥969.5 M

FY, 2025

Immuno-Biological Laboratories Summary

Company Summary

Overview
Immuno-Biological Laboratories (IBL) is a company that specializes in medicine research and development. It manufactures and supplies various immunological reagents, including ELISA kits, antibodies, cell culture-related products, etc. In addition, the company is engaged in the development of technology for protein production using transgenic silkworm cocoons. IBL focuses on inflammatory, neurodegenerative, lipid metabolism, and other diseases.
Type
Public
Status
Active
Founded
1982
HQ
Fujioka, JP | view all locations
Website
https://www.ibl-japan.co.jp/
Cybersecurity rating
Sectors

LocationsView all

1 location detected

  • Fujioka, Gunma HQ

    Japan

    Naka

Immuno-Biological Laboratories Financials

Summary Financials

Revenue (Q3, 2026)
¥742.2M
Gross profit (Q3, 2026)
¥545.3M
Net income (Q3, 2026)
¥248.2M
Cash (Q3, 2026)
¥893.3M
EBIT (Q3, 2026)
¥231.3M
Enterprise value
$4.1B

Footer menu